| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.44 | 2e-10 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.43 | 0.004 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.37 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.37 | 5e-09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.35 | 6e-08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.35 | 4e-07 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.35 | 0.08 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.33 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.33 | 0.09 |